Bill · started in the Commons
Off-patent Drugs Bill
A Bill to require the Secretary of State to take steps to secure licences for off-patent drugs in new indications; to require the National Institute for Health and Care Excellence to conduct technology appraisals for off-patent drugs in new indications; and for connected purposes.
In progress
Current stage: 2nd reading (Commons)
The story so farThe Off-patent Drugs Bill was introduced in the House of Commons on 2 July 2014 by Jonathan Evans (Conservative). It is now at second reading in the House of Commons. Second reading is the first debate on the overall principle of the bill; if the bill clears it, detailed committee scrutiny follows.
Progress through Parliament
- 1st reading Commons 2 Jul 2014
- 2nd reading Commons 7 Nov 2014
Source: the official bill page. Last updated 30 Mar 2015.